Michael A. Panzara - Jan 1, 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Medical Officer, Head of Therapeutics Discovery and Development
Signature
/s/ Michael A. Panzara
Stock symbol
WVE
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 08:18 PM
Next filing
Feb 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +200K $0.00 200K Jan 1, 2022 Ordinary Shares 200K $3.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.

Remarks:

Chief Medical Officer, Head of Therapeutics Discovery and Development